Cited by 7Protein Kinase Regulation and GTPase SignalingProtein Structure and DynamicsReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Comparative MD simulations and advanced analytics based studies on wild-type and hot-spot mutant A59G HRas

Open access

Published version of a preprint

Abstract

The Ras family of proteins is known to play an important role in cellular signal transduction. The oncoprotein Ras is also found to be mutated in ~90% of the pancreatic cancers, of which G12V, G13V, A59G and Q61L are the known hot-spot mutants. These ubiquitous proteins fall in the family of G-proteins, and hence switches between active GTP bound and inactive GDP bound states, which is hindered in most of its oncogenic mutant counterparts. Moreover, Ras being a GTPase has an intrinsic property to hydrolyze GTP to GDP, which is obstructed due to mutations and lends the mutants stuck in constitutively active state leading to oncogenic behavior. In this regard, the present study aims to understand the dynamics involved in the hot-spot mutant A59G-Ras using long 10μs classical MD simulations (5μs for each of the wild-type and mutant systems) and comparing the same with its wild-type counterpart. Advanced analytics using Markov State Model (MSM) based approach has been deployed to comparatively understand the transition path for the wild-type and mutant systems. Roles of crucial residues like Tyr32, Gln61 and Tyr64 have also been established using multivariate PCA analyses. Furthermore, this multivariate PCA analysis also provides crucial features which may be used as reaction coordinates for biased simulations for further studies. The absence of formation of pre-hydrolysis network is also reported for the mutant conformation, using the distance-based analyses (between crucial residues) of the conserved regions. The implications of this study strengthen the hypothesis that the disruption of the pre-hydrolysis network in the mutant A59G ensemble might lead to permanently active oncogenic conformation in the mutant conformers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0234836

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 2D-plot showing RMSD trend for the wild-type and mutant simulationW and simulationM, respectively. The mutant system showed a fluctuating SwII region as compared to its wild-type counterpart.
Fig 1 2D-plot showing RMSD trend for the wild-type and mutant simulationW and simulationM, respectively. The mutant system showed a fluctuating SwII region as compared to its wild-type counterpart.CC BY · PubMed Central
Fig 2 2D-plot showing RMSF trend for the wild-type and mutant simulationW (black line) and simulationM (red line), respectively. The regions showing changes are labelled accordingly.
Fig 2 2D-plot showing RMSF trend for the wild-type and mutant simulationW (black line) and simulationM (red line), respectively. The regions showing changes are labelled accordingly.CC BY · PubMed Central
Fig 3 Overlaps of the wild-type and mutant simulation trajectories to depict the deviation in the selected regions in dotted ovals (gray for wild-type and yellow for A59G mutant). The wild-type and mutant trajectories are shown in blue and red cartoon representations, respectively.
Fig 3 Overlaps of the wild-type and mutant simulation trajectories to depict the deviation in the selected regions in dotted ovals (gray for wild-type and yellow for A59G mutant). The wild-type and mutant trajectories are shown in blue and red cartoon representations, respectively.CC BY · PubMed Central
Fig 4 2-D plot showing number of conformers for Gln61 residue’s interaction with Lys16, Ser17, Thr35, Tyr32 and Tyr64. Black and red lines represent trends for the wild-type and mutant systems, respectively.
Fig 4 2-D plot showing number of conformers for Gln61 residue’s interaction with Lys16, Ser17, Thr35, Tyr32 and Tyr64. Black and red lines represent trends for the wild-type and mutant systems, respectively.CC BY · PubMed Central
Fig 5 2-D plot showing number of conformers for Gly60 residue’s interaction with Lys16, and Ser17. Black and red lines represent trends for the wild-type and mutant systems, respectively.
Fig 5 2-D plot showing number of conformers for Gly60 residue’s interaction with Lys16, and Ser17. Black and red lines represent trends for the wild-type and mutant systems, respectively.CC BY · PubMed Central
Fig 6 2-D plot showing number of conformers for Tyr64 residue’s interaction with Lys16, Ser17, Thr35 and Tyr32. Black and red lines represent trends for the wild-type and mutant systems, respectively.
Fig 6 2-D plot showing number of conformers for Tyr64 residue’s interaction with Lys16, Ser17, Thr35 and Tyr32. Black and red lines represent trends for the wild-type and mutant systems, respectively.CC BY · PubMed Central
Fig 7 2-D plot showing the segregation of wild-type and mutant simulation trajectories, on the basis of phi(Φ) and psi(ψ) dihedrals values. Black color depicts the wild-type and red color represents the A59G-mutant cluster.
Fig 7 2-D plot showing the segregation of wild-type and mutant simulation trajectories, on the basis of phi(Φ) and psi(ψ) dihedrals values. Black color depicts the wild-type and red color represents the A59G-mutant cluster.CC BY · PubMed Central
Fig 8 The 2-D plot showing the projections of wild-type (green) and mutant (red) trajectories, using multivariate PCA approach. A combination of dihedral, interactions and energy were used as features, as labelled on the X and Y axis.
Fig 8 The 2-D plot showing the projections of wild-type (green) and mutant (red) trajectories, using multivariate PCA approach. A combination of dihedral, interactions and energy were used as features, as labelled on the X and Y axis.CC BY · PubMed Central
Fig 9 Projections of PC1 on PC2, of the features chosen for multivariate PCA. Cyan and orange color clusters are for wild-type and mutant trajectories, respectively. The individual arrows represent the eight features used for this analysis.
Fig 9 Projections of PC1 on PC2, of the features chosen for multivariate PCA. Cyan and orange color clusters are for wild-type and mutant trajectories, respectively. The individual arrows represent the eight features used for this analysis.CC BY · PubMed Central
Fig 10 Depiction of metastable clusters for the wild-type and mutant trajectories, represented by numbers, as captured using PyEMMA while performing MSM based analysis. The feature used was Cadist (distances between the C-alpha atoms of the respective trajectories).
Fig 10 Depiction of metastable clusters for the wild-type and mutant trajectories, represented by numbers, as captured using PyEMMA while performing MSM based analysis. The feature used was Cadist (distances between the C-alpha atoms of the respective trajectories).CC BY · PubMed Central
Fig 11 The 2D-plot demonstrating the probable pathways for the wild-type and mutant simulations, calculated using PyEMMA. The most probable pathway is denoted by a bold gray arrow (rightmost to left most cluster). The committor probability of each state transition is written along the respective arrow.
Fig 11 The 2D-plot demonstrating the probable pathways for the wild-type and mutant simulations, calculated using PyEMMA. The most probable pathway is denoted by a bold gray arrow (rightmost to left most cluster). The committor probability of each state transition is written along the respective arrow.CC BY · PubMed Central
Fig 12 Fig showing the overlap of representative structures of the cluster 5 (mutant), cluster 1 (wild-type and mutant), from the respective MSM based analysis. Yellow CPK representation shows the mutant conformation from cluster 5 (sparsely populated) and the most probable conformations of wild-type and mutant trajectories, from the respective cluster 1.
Fig 12 Fig showing the overlap of representative structures of the cluster 5 (mutant), cluster 1 (wild-type and mutant), from the respective MSM based analysis. Yellow CPK representation shows the mutant conformation from cluster 5 (sparsely populated) and the most probable conformations of wild-type and mutant trajectories, from the respective cluster 1.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 61

  1. E Castellano, 2011, Functional specificity of ras isoforms: so similar but so different., Genes Cancer, 2, 216, 10.1177/1947601911408081 · DOI
  2. GA Hobbs, 2016, RAS isoforms and mutations in cancer at a glance, J Cell Sci, 129, 1287, 10.1242/jcs.182873 · DOI · Paper page
  3. MF Olson, 2000, Ras protein signalling., Semin Immunol., 12, 63, 10.1006/smim.2000.0208 · DOI
  4. Y Takai, 2001, Small GTP-binding proteins., Physiol Rev, 81, 153, 10.1152/physrev.2001.81.1.153 · DOI
  5. D Matallanas, 2011, Raf family kinases: old dogs have learned new tricks., Genes Cancer, 2, 232, 10.1177/1947601911407323 · DOI
  6. PJ Kraulis, 1994, Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy, Biochemistry, 33, 3515, 10.1021/bi00178a008 · DOI
  7. MV Milburn, 1990, Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins, Science, 247, 939, 10.1126/science.2406906 · DOI
  8. M. Barbacid, 1987, ras genes., Annu Rev Biochem, 56, 779, 10.1146/annurev.bi.56.070187.004023 · DOI · Paper page
  9. F Raimondi, 2011, Nucleotide binding switches the information flow in ras GTPases., PLoS Comput Biol, 7, e1001098, 10.1371/journal.pcbi.1001098 · DOI
  10. DK Simanshu, 2017, RAS Proteins and Their Regulators in Human Disease, Cell, 170, 17, 10.1016/j.cell.2017.06.009 · DOI · Paper page
  11. R Gasper, 2010, GTPase activity of Di-Ras proteins is stimulated by Rap1GAP proteins., Small GTPases., 1, 133, 10.4161/sgtp.1.3.14742 · DOI
  12. DS Goodsell, 1999, The molecular perspective: the ras oncogene, Oncologist, 4, 263, 10.1634/theoncologist.4-3-263 · DOI
  13. BJ Grant, 2009, Ras conformational switching: simulating nucleotide-dependent conformational transitions with accelerated molecular dynamics., PLoS Comput Biol., 5, e1000325, 10.1371/journal.pcbi.1000325 · DOI
  14. K Scheffzek, 1997, The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants, Science, 277, 333, 10.1126/science.277.5324.333 · DOI · Paper page
  15. JL Bos, 2007, GEFs and GAPs: critical elements in the control of small G proteins, Cell, 129, 865, 10.1016/j.cell.2007.05.018 · DOI · Paper page
  16. TM Glennon, 2000, How does GAP catalyze the GTPase reaction of Ras? A computer simulation study, Biochemistry, 39, 9641, 10.1021/bi000640e · DOI
  17. J Cherfils, 1999, GEFs: structural basis for their activation of small GTP-binding proteins, Trends Biochem Sci, 24, 306, 10.1016/S0968-0004(99)01429-2 · DOI
  18. AJ Scheidig, 1999, The pre-hydrolysis state of p21(ras) in complex with GTP: new insights into the role of water molecules in the GTP hydrolysis reaction of ras-like proteins., Structure, 7, 1311, 10.1016/S0969-2126(00)80021-0 · DOI
  19. H te Heesen, 2007, Role of the arginine finger in Ras.RasGAP revealed by QM/MM calculations, FEBS Lett, 581, 5677, 10.1016/j.febslet.2007.11.026 · DOI
  20. MG Khrenova, 2015, Hydrolysis of Guanosine Triphosphate (GTP) by the Ras·GAP Protein Complex: Reaction Mechanism and Kinetic Scheme., J Phys Chem B, 119, 12838, 10.1021/acs.jpcb.5b07238 · DOI
  21. S Schubbert, 2007, Hyperactive Ras in developmental disorders and cancer, Nat Rev Cancer, 7, 295, 10.1038/nrc2109 · DOI · Paper page
  22. S Lukman, 2010, The distinct conformational dynamics of K-Ras and H-Ras A59G., PLoS Comput Biol., 6, e1000922, 10.1371/journal.pcbi.1000922 · DOI
  23. BJ Grant, 2011, Novel allosteric sites on Ras for lead generation., PLoS One., 6, e25711, 10.1371/journal.pone.0025711 · DOI
  24. HJ Hocker, Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function, Proc Natl Acad Sci U S A, 110, 10201, 10.1073/pnas.1300016110 · DOI
  25. A Shurki, 2004, Why does the Ras switch "break" by oncogenic mutations?, Proteins, 55, 1, 10.1002/prot.20004 · DOI
  26. C Gao, 2013, Impact of Mutations on K-Ras-p120GAP Interaction., Computational Molecular Bioscience, 3, 9, 10.4236/cmb.2013.32002 · DOI
  27. AA Adjei, 2001, Blocking oncogenic Ras signaling for cancer therapy, J Natl Cancer Inst, 93, 1062, 10.1093/jnci/93.14.1062 · DOI
  28. J. Downward, 2003, Targeting RAS signalling pathways in cancer therapy, Nat Rev Cancer, 3, 11, 10.1038/nrc969 · DOI
  29. CK Foley, 1992, Simulation of the solution structure of the H-ras p21-GTP complex., Biochemistry, 31, 4951, 10.1021/bi00136a005 · DOI
  30. JF Díaz, 1995, Molecular dynamics simulation of the solution structures of Ha-ras-p21 GDP and GTP complexes: flexibility, possible hinges, and levers of the conformational transition, Biochemistry, 34, 12038, 10.1021/bi00037a047 · DOI
  31. S Kuppens, 2003, Conformational states of the switch I region of Ha-ras-p21 in hinge residue mutants studied by fluorescence lifetime and fluorescence anisotropy measurements, Protein Sci, 12, 930, 10.1110/ps.0236303 · DOI
  32. BL Grigorenko, 2007, Mechanisms of guanosine triphosphate hydrolysis by Ras and Ras-GAP proteins as rationalized by ab initio QM/MM simulations, Proteins, 66, 456, 10.1002/prot.21228 · DOI
  33. F Xia, 2011, The specific vibrational modes of GTP in solution and bound to Ras: a detailed theoretical analysis by QM/MM simulations, Phys Chem Chem Phys, 13, 21451, 10.1039/c1cp22741f · DOI
  34. P Prakash, 2014, Overview of simulation studies on the enzymatic activity and conformational dynamics of the GTPase Ras., Mol Simul., 40, 839, 10.1080/08927022.2014.895000 · DOI
  35. N Sharma, 2014, Probing the wild-type HRas activation mechanism using steered molecular dynamics, understanding the energy barrier and role of water in the activation, Eur Biophys J, 43, 81, 10.1007/s00249-014-0942-4 · DOI
  36. P Prakash, 2012, The role of conserved waters in conformational transitions of Q61H K-ras., PLoS Comput Biol., 8, e1002394, 10.1371/journal.pcbi.1002394 · DOI
  37. EF Pai, 1990, Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis, EMBO J, 9, 2351, 10.1002/j.1460-2075.1990.tb07409.x · DOI
  38. MJ Smith, 2013, NMR-based functional profiling of RASopathies and oncogenic RAS mutations, Proc Natl Acad Sci U S A, 110, 4574, 10.1073/pnas.1218173110 · DOI · Paper page
  39. MG Khrenova, 2014, Modeling the role of G12V and G13V Ras mutations in the Ras-GAP-catalyzed hydrolysis reaction of guanosine triphosphate, Biochemistry, 53, 7093, 10.1021/bi5011333 · DOI
  40. BL Grigorenko, 2005, QM/MM modeling the Ras-GAP catalyzed hydrolysis of guanosine triphosphate, Proteins, 60, 495, 10.1002/prot.20472 · DOI
  41. F Martín-García, 2012, The Role of Gln61 in HRas GTP hydrolysis: a quantum mechanics/molecular mechanics study, Biophys J, 102, 152, 10.1016/j.bpj.2011.11.4005 · DOI
  42. S Muraoka, 2012, Crystal structures of the state 1 conformations of the GTP-bound H-Ras protein and its oncogenic G12V and Q61L mutants., FEBS Lett, 586, 1715, 10.1016/j.febslet.2012.04.058 · DOI
  43. BE Hall, 2002, The structural basis for the transition from Ras-GTP to Ras-GDP, Proc Natl Acad Sci U S A, 99, 12138, 10.1073/pnas.192453199 · DOI
  44. N Sharma, 2017, Differentiating the pre-hydrolysis states of wild-type and A59G mutant HRas: An insight through MD simulations, Comput Biol Chem, 69, 96, 10.1016/j.compbiolchem.2017.05.008 · DOI
  45. FC Bernstein, 1977, The Protein Data Bank: a computer-based archival file for macromolecular structures, J Mol Biol, 112, 535, 10.1016/S0022-2836(77)80200-3 · DOI
  46. B Hess, 2008, GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation., J Chem Theory Comput., 4, 435, 10.1021/ct700301q · DOI
  47. V Hornak, 2006, Comparison of multiple Amber force fields and development of improved protein backbone parameters, Proteins, 65, 712, 10.1002/prot.21123 · DOI
  48. AW Schüttelkopf, 2004, PRODRG: a tool for high-throughput crystallography of protein-ligand complexes, Acta Crystallogr D Biol Crystallogr, 60, 1355, 10.1107/S0907444904011679 · DOI
  49. EF Pettersen, 2004, UCSF Chimera—a visualization system for exploratory research and analysis, J Comput Chem, 25, 1605, 10.1002/jcc.20084 · DOI
  50. W Humphrey, 1996, VMD: visual molecular dynamics, J Mol Graph, 14, 33, 10.1016/0263-7855(96)00018-5 · DOI · Paper page
  51. MK Scherer, 2015, PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models., J Chem Theory Comput., 11, 5525, 10.1021/acs.jctc.5b00743 · DOI
  52. JD Chodera, 2007, Automatic discovery of metastable states for the construction of Markov models of macromolecular conformational dynamics, J Chem Phys, 126, 155101, 10.1063/1.2714538 · DOI
  53. A Sirur, 2016, Markov state models of protein misfolding, J Chem Phys, 144, 075101, 10.1063/1.4941579 · DOI
  54. H Wu, 2020, Variational Approach for Learning Markov Processes from Time Series Data, J Nonlinear Sci, 30, 23, 10.1007/s00332-019-09567-y · DOI
  55. F Noé, 2009, Constructing the equilibrium ensemble of folding pathways from short off-equilibrium simulations. Version 2, Proc Natl Acad Sci U S A, 106, 19011, 10.1073/pnas.0905466106 · DOI · Paper page
  56. B Ford, 2006, Structure of a transient intermediate for GTP hydrolysis by ras, Structure, 14, 427, 10.1016/j.str.2005.12.010 · DOI
  57. J Chen, 2020, Unveiling conformational dynamics changes of H-Ras induced by mutations based on accelerated molecular dynamics, Phys Chem Chem Phys
  58. DK Menyhárd, 2020, Structural impact of GTP binding on downstream KRAS signaling., Chem Sci., 11, 9272, 10.1039/D0SC03441J · DOI
  59. SF Altschul, 1990, Basic local alignment search tool, J Mol Biol, 215, 403, 10.1016/S0022-2836(05)80360-2 · DOI · Paper page
  60. T. Pantsar, 2019, The current understanding of KRAS protein structure and dynamics, Comput Struct Biotechnol J, 18, 189, 10.1016/j.csbj.2019.12.004 · DOI
  61. J Lu, 2018, KRAS Switch Mutants D33E and A59G Crystallize in the State 1 Conformation., Biochemistry, 57, 324, 10.1021/acs.biochem.7b00974 · DOI

Metadata

Authors
Sharma, N., Sonavane, U., & Joshi, R.
Affiliations
Centre for Development of Advanced Computing (IN)
Corresponding author
Joshi, Rajendra
Venue
PLOS ONE
Published
2020-10-16
Volume
15
Issue
10
Pages
e0234836
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3092863994
Cited by
7
References
6
Citations by year
2025: 1 · 2024: 2 · 2023: 4
FWCI
0.32
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Patient Safety Foundation
  • Ministry of Electronics and Information technology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
HRAS, Ras GTPase, GTP hydrolysis, GTP/GDP binding, Markov state models, transition pathways, reaction coordinate, pancreatic cancer
MeSH terms
Guanosine Diphosphate, Guanosine Triphosphate, Humans, Hydrolysis, Mutation, Proto-Oncogene Proteins p21(ras), Molecular Dynamics Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative MD simulations and advanced analytics based studies on wild-type and hot-spot mutant A59G HRas. https://app.cochat.ai/papers/10.1371/journal.pone.0234836
The paper
Sharma, N., Sonavane, U., & Joshi, R. (2020). Comparative MD simulations and advanced analytics based studies on wild-type and hot-spot mutant A59G HRas. PLOS ONE. https://doi.org/10.1371/journal.pone.0234836